Fibrin-depolymerization activity and the antiplatelet effect of small cyclic and linear proline-containing peptides

Biology Bulletin

Volumn 28, Issue 5, 2001, Pages 504-507

  Pastorova, V E ^a   Lyapina, L A ^a   Ashmarin, I P ^a   Ostrovskaya, R U ^b   Gudasheva, T A ^b   Lugovskoi, E V ^c  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^c PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034787284     PISSN: 10623590     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016700412205     Document Type: Article

References (16)

1. Modulation of in vitro and in vivo hemostatic reactions using representatives of the families of regulatory peptides
2. The effect of the simplest proline-containing peptides on the functional activity of the anticoagulant system and primary hemostasis
3. Cyclic RGD peptide analogues as antiplatelets antithrombotics
4. Aggregation of blood platelets by adenosindiphosphate and its reversal
5. Conversion of fibrin to desmofibrin
6. Comparative pharmacology of site directed antithrombin agents
7. Crystal structures of fragments D and double-D from fibrinogen and fibrin
8. Conformational changes in fragments D or double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-Amide
9. A novel approach to the design of potent bioactive peptides by incorporation of proline brackets: Antiplatelet effect of Arg-Gly-Asp peptides
10. Improved method of determination of nonenzymatic fibrinolytic activity of blood plasma and some of its fractions
11. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences
12. Antithrombotic and thrombolytic activities of tufsin
13. Anticoagulant and fibrinolytic effects of the simplest proline-containing peptides
14. The fibrin polymerization pocket: Three-dimensional structure of a 30 kDa C-terminal γ-chain fragment complexed with the peptide Gly-Pro-Arg-Pro
15. Clinical trials of platelet receptor inhibitors